Efficacy and Safety of Sofosbuvir-Based Antiviral Therapy to Treat Hepatitis C Virus Infection After Kidney Transplantation

American Journal of Transplantation - United Kingdom
doi 10.1111/ajt.13518
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Hepatitis C Virus Resistance to Antiviral Therapy

Hepatology
MedicineHepatology
2000English

Ledipasvir and Sofosbuvir for Recurrent Hepatitis C After Liver Transplantation

BioScience Trends
BiochemistryHealthMedicineGeneticsMolecular Biology
2016English

Efficacy of Glecaprevir and Pibrentasvir in Patients With Genotype 1 Hepatitis C Virus Infection With Treatment Failure After NS5A Inhibitor Plus Sofosbuvir Therapy

Gastroenterology
HepatologyGastroenterology
2019English

NS5A-P32 Deletion After Failure of Ledipasvir/Sofosbuvir in Hepatitis C Virus Genotype 1b Infection

Hepatology
MedicineHepatology
2018English

Very Late Relapse of Hepatitis C Virus Infection Immediately After Liver Transplantation

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2018English

Hepatitis C Virus Infected Kidney Wait List Patients: Treat Now or Treat Later?

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2018English

Hepatitis C Virus Recurrence After Liver Transplantation

Gut
Gastroenterology
1999English

Persistent Hepatitis C Virus-Associated Cryoglobulinemic Vasculitis Following Virus Eradication After Direct-Acting Antiviral Therapy

Hepatology
MedicineHepatology
2017English

Secondary Occult Hepatitis C Virus Infection (HCV) in Chronic HCV Patients After Treatment With Sofosbuvir and Daclatasvir

International Journal of Current Microbiology and Applied Sciences
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy